However, studies using animal models of stroke have indicated that tPA may exert serious side effects in the ischemic brain which include blood-brain barrier (BBB) breakdown [4-6] frequently resulting in intracerebral bleeding if systemic tPA is administered 3-4 h after stroke [7,8]. This evidence concerns the gene PLAT and stroke disorder.